YM-458

N/A

Report date: 2022/06/29 15:07:12
NME

Base Information

Drug NameYM-458
Drug Alias NameYM-458
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitorsBromodomain-containing protein 4 inhibitors
TargetsHistone-lysine N-methyltransferase EZH2Bromodomain-containing protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCancer Center Of Sun Yat Sen University
China Registration ClassN/A

Develop Information

Active CompaniesCancer Center Of Sun Yat Sen University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A